Standardization of retinopathy of prematurity clinical examinations in clinical trials: Risks, benefits and alternatives

Clinical and Experimental Ophthalmology

Volumn 36, Issue 1, 2008, Pages 1-2

  Good, William V ^a  

^a SMITH KETTLEWELL EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE MEDICINE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; EDITORIAL; EYE PHOTOGRAPHY; HEALTH CARE QUALITY; HUMAN; MEDICAL DECISION MAKING; MORBIDITY; OPHTHALMOLOGY; OPHTHALMOSCOPY; PATIENT CARE; PATIENT COMPLIANCE; QUALITY OF LIFE; RETROLENTAL FIBROPLASIA; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STANDARDIZATION;

AUSTRALIA; CLINICAL TRIALS AS TOPIC; HUMANS; INCIDENCE; INFANT, NEWBORN; NEW ZEALAND; OBSERVER VARIATION; PHYSICAL EXAMINATION; RETINOPATHY OF PREMATURITY; RISK ASSESSMENT;

EID: 39649099349     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2008.01673.x     Document Type: Editorial

References (1)

1. Darlow BA, Elder MJ, Horwood LJ, Donoghue DA, Henderson-Smart DJ. Does observer bias contribute to variations in the rate of retinopathy of prematurity between centres? Clin Experiment Ophthalmol 2008; 36: 43-6.